NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus
NorthStrive Biosciences, a subsidiary of PMGC Holdings Inc., has signed a third amendment to its existing License Agreement with MOA Life Plus Co. Ltd., a Korean biotechnology company, to update the timing and key development milestones for EL-32 and EL-22 human clinical development programs.